SCHEMBL25532256

SCHEMBL25532256

CCOC(=O)C1(CNC(=O)OCc2ccccc2)CNC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
OPRM1 P35372 1/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 2/20 0.43
KMT2A Q03164 2/20 0.43
HTR2C P28335 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL22233162 0.93 MEN1 (0.44) LMNASMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL25532258 0.89 LMNA (0.48) LMNASMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL6203374 0.88 CTSL (0.51) LMNASMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL7841236 0.83 MEN1 (0.53) LMNAL3MBTL1NPC1RAB9AMAPT
SCHEMBL15055328 0.79 LMNA (0.48) LMNASMN1; SMN2HTTCTSLCTSB
SCHEMBL6187228 0.78 ITGB3 (0.51) LMNASMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL6191239 0.78 MEN1 (0.48) LMNANPC1RAB9AMAPTMEN1
SCHEMBL22233159 0.78 SYK (0.46) LMNAL3MBTL1NPC1RAB9AMEN1
SCHEMBL29561117 0.78 LMNA (0.52) LMNASMN1; SMN2L3MBTL1HTTMEN1
Hydrochloric Acid SCHEMBL28137469 0.78 LMNA (0.47) LMNASMN1; SMN2HTTCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159491-A1 Antimicrobial Compounds and Methods MPO, NISCH, RPN2 LMNA 3813/4885SMN1; SMN2 4817/4885L3MBTL1 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.